Disruptive technologies, developing drugs, and building companies to treat disease

Prof. Harvey Lodish will share some of his experiences as a researcher who has been active in biotechnology industry for over 35 years. He has started 7 companies including Genzyme and Millennium, and most recently Rubius, a company that is developing engineered red cells as a vehicle for introducing into the human body novel therapeutics that function for several months.